Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme

Identifieur interne : 004D38 ( Main/Exploration ); précédent : 004D37; suivant : 004D39

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme

Auteurs : Holger A. Lindner [Canada] ; Nasser Fotouhi-Ardakani [Canada] ; Viktoria Lytvyn [Canada] ; Paule Lachance [Canada] ; Traian Sulea [Canada] ; Robert Menard [Canada]

Source :

RBID : Pascal:06-0040397

Descripteurs français

English descriptors

Abstract

The severe acute respiratory syndrome coronavirus papain-like protease (SARS-CoV PLpro) is involved in the processing of the viral polyprotein and, thereby, contributes to the biogenesis of the virus replication complex. Structural bioinformatics has revealed a relationship for the SARS-CoV PLpro to herpesvirus-associated ubiquitin-specific protease (HAUSP), a ubiquitin-specific protease, indicating potential deubiquitinating activity in addition to its function in polyprotein processing (T. Sulea, H. A. Lindner, E. O. Purisima, and R. Menard, J. Virol. 79:4550-4551, 2005). In order to confirm this prediction, we overexpressed and purified SARS-CoV PLpro (amino acids [aa]1507 to 1858) from Escherichia coli. The purified enzyme hydrolyzed ubiquitin-7-amino-4-methylcoumarin (Ub-AMC), a general deubiquitinating enzyme substrate, with a catalytic efficiency of 13,100 M-1s-1, 220-fold more efficiently than the small synthetic peptide substrate Z-LRGG-AMC, which incorporates the C-terminal four residues of ubiquitin. In addition, SARS-CoV PLpro was inhibited by the specific deubiquitinating enzyme inhibitor ubiquitin aldehyde, with an inhibition constant of 210 nM. The purified SARS-CoV PLpro disassembles branched polyubiquitin chains with lengths of two to seven (Ub2-7) or four (Ub4) units, which involves isopeptide bond cleavage. SARS-CoV PLpro processing activity was also detected against a protein fused to the C terminus of the ubiquitin-like modifier ISG15, both in vitro using the purified enzyme and in HeLa cells by coexpression with SARS-CoV PLpro (aa 1198 to 2009). These results clearly establish that SARS-CoV PLpro is a deubiquitinating enzyme, thereby confirming our earlier prediction. This unexpected activity for a coronavirus papain-like protease suggests a novel viral strategy to modulate the host cell ubiquitination machinery to its advantage.

Url:


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme</title>
<author>
<name sortKey="Lindner, Holger A" sort="Lindner, Holger A" uniqKey="Lindner H" first="Holger A." last="Lindner">Holger A. Lindner</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fotouhi Ardakani, Nasser" sort="Fotouhi Ardakani, Nasser" uniqKey="Fotouhi Ardakani N" first="Nasser" last="Fotouhi-Ardakani">Nasser Fotouhi-Ardakani</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lytvyn, Viktoria" sort="Lytvyn, Viktoria" uniqKey="Lytvyn V" first="Viktoria" last="Lytvyn">Viktoria Lytvyn</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lachance, Paule" sort="Lachance, Paule" uniqKey="Lachance P" first="Paule" last="Lachance">Paule Lachance</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sulea, Traian" sort="Sulea, Traian" uniqKey="Sulea T" first="Traian" last="Sulea">Traian Sulea</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Menard, Robert" sort="Menard, Robert" uniqKey="Menard R" first="Robert" last="Menard">Robert Menard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0040397</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0040397 INIST</idno>
<idno type="RBID">Pascal:06-0040397</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000562</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000428</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000546</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000546</idno>
<idno type="wicri:doubleKey">0022-538X:2005:Lindner H:the:papain:like</idno>
<idno type="wicri:Area/Main/Merge">005066</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1316033</idno>
<idno type="RBID">PMC:1316033</idno>
<idno type="wicri:Area/Pmc/Corpus">000702</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000702</idno>
<idno type="wicri:Area/Pmc/Curation">000702</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000702</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001213</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001213</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16306591</idno>
<idno type="wicri:Area/PubMed/Corpus">002434</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002434</idno>
<idno type="wicri:Area/PubMed/Curation">002434</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002434</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002426</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002426</idno>
<idno type="wicri:Area/Ncbi/Merge">001278</idno>
<idno type="wicri:Area/Ncbi/Curation">001278</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001278</idno>
<idno type="wicri:doubleKey">0022-538X:2005:Lindner H:the:papain:like</idno>
<idno type="wicri:Area/Main/Merge">004845</idno>
<idno type="wicri:Area/Main/Curation">004D38</idno>
<idno type="wicri:Area/Main/Exploration">004D38</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme</title>
<author>
<name sortKey="Lindner, Holger A" sort="Lindner, Holger A" uniqKey="Lindner H" first="Holger A." last="Lindner">Holger A. Lindner</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fotouhi Ardakani, Nasser" sort="Fotouhi Ardakani, Nasser" uniqKey="Fotouhi Ardakani N" first="Nasser" last="Fotouhi-Ardakani">Nasser Fotouhi-Ardakani</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lytvyn, Viktoria" sort="Lytvyn, Viktoria" uniqKey="Lytvyn V" first="Viktoria" last="Lytvyn">Viktoria Lytvyn</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lachance, Paule" sort="Lachance, Paule" uniqKey="Lachance P" first="Paule" last="Lachance">Paule Lachance</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sulea, Traian" sort="Sulea, Traian" uniqKey="Sulea T" first="Traian" last="Sulea">Traian Sulea</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Menard, Robert" sort="Menard, Robert" uniqKey="Menard R" first="Robert" last="Menard">Robert Menard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue</s1>
<s2>Montreal, Quebec, H4P 2R2</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, Quebec, H4P 2R2</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Catalytic Domain</term>
<term>Coronavirus</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Microbiology</term>
<term>Molecular Sequence Data</term>
<term>Papain</term>
<term>Papain (chemistry)</term>
<term>Papain (metabolism)</term>
<term>Peptide Hydrolases (genetics)</term>
<term>Peptide Hydrolases (metabolism)</term>
<term>SARS Virus (enzymology)</term>
<term>SARS Virus (genetics)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Severe acute respiratory syndrome</term>
<term>Substrate Specificity</term>
<term>Ubiquitin (metabolism)</term>
<term>Virology</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cellules HeLa</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Papaïne ()</term>
<term>Papaïne (métabolisme)</term>
<term>Peptide hydrolases (génétique)</term>
<term>Peptide hydrolases (métabolisme)</term>
<term>Spécificité du substrat</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Séquence d'acides aminés</term>
<term>Ubiquitine (métabolisme)</term>
<term>Virus du SRAS (enzymologie)</term>
<term>Virus du SRAS (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Papain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Peptide Hydrolases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Papain</term>
<term>Peptide Hydrolases</term>
<term>Ubiquitin</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Peptide hydrolases</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Papaïne</term>
<term>Peptide hydrolases</term>
<term>Ubiquitine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Catalytic Domain</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Molecular Sequence Data</term>
<term>Substrate Specificity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Cellules HeLa</term>
<term>Coronavirus</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Papain</term>
<term>Microbiologie</term>
<term>Papaïne</term>
<term>Spécificité du substrat</term>
<term>Séquence d'acides aminés</term>
<term>Virologie</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The severe acute respiratory syndrome coronavirus papain-like protease (SARS-CoV PLpro) is involved in the processing of the viral polyprotein and, thereby, contributes to the biogenesis of the virus replication complex. Structural bioinformatics has revealed a relationship for the SARS-CoV PLpro to herpesvirus-associated ubiquitin-specific protease (HAUSP), a ubiquitin-specific protease, indicating potential deubiquitinating activity in addition to its function in polyprotein processing (T. Sulea, H. A. Lindner, E. O. Purisima, and R. Menard, J. Virol. 79:4550-4551, 2005). In order to confirm this prediction, we overexpressed and purified SARS-CoV PLpro (amino acids [aa]1507 to 1858) from Escherichia coli. The purified enzyme hydrolyzed ubiquitin-7-amino-4-methylcoumarin (Ub-AMC), a general deubiquitinating enzyme substrate, with a catalytic efficiency of 13,100 M
<sup>-1</sup>
s
<sup>-1</sup>
, 220-fold more efficiently than the small synthetic peptide substrate Z-LRGG-AMC, which incorporates the C-terminal four residues of ubiquitin. In addition, SARS-CoV PLpro was inhibited by the specific deubiquitinating enzyme inhibitor ubiquitin aldehyde, with an inhibition constant of 210 nM. The purified SARS-CoV PLpro disassembles branched polyubiquitin chains with lengths of two to seven (Ub2-7) or four (Ub4) units, which involves isopeptide bond cleavage. SARS-CoV PLpro processing activity was also detected against a protein fused to the C terminus of the ubiquitin-like modifier ISG15, both in vitro using the purified enzyme and in HeLa cells by coexpression with SARS-CoV PLpro (aa 1198 to 2009). These results clearly establish that SARS-CoV PLpro is a deubiquitinating enzyme, thereby confirming our earlier prediction. This unexpected activity for a coronavirus papain-like protease suggests a novel viral strategy to modulate the host cell ubiquitination machinery to its advantage.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Lindner, Holger A" sort="Lindner, Holger A" uniqKey="Lindner H" first="Holger A." last="Lindner">Holger A. Lindner</name>
</noRegion>
<name sortKey="Fotouhi Ardakani, Nasser" sort="Fotouhi Ardakani, Nasser" uniqKey="Fotouhi Ardakani N" first="Nasser" last="Fotouhi-Ardakani">Nasser Fotouhi-Ardakani</name>
<name sortKey="Lachance, Paule" sort="Lachance, Paule" uniqKey="Lachance P" first="Paule" last="Lachance">Paule Lachance</name>
<name sortKey="Lytvyn, Viktoria" sort="Lytvyn, Viktoria" uniqKey="Lytvyn V" first="Viktoria" last="Lytvyn">Viktoria Lytvyn</name>
<name sortKey="Menard, Robert" sort="Menard, Robert" uniqKey="Menard R" first="Robert" last="Menard">Robert Menard</name>
<name sortKey="Sulea, Traian" sort="Sulea, Traian" uniqKey="Sulea T" first="Traian" last="Sulea">Traian Sulea</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D38 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004D38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:06-0040397
   |texte=   The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021